GRAIL is a leader in innovating new technologies to improve cancer screening. Dedicated to easing cancer’s global impact, GRAIL uses advanced DNA sequencing, conducts extensive clinical studies, and employs cutting-edge technology—all aligned to help detect multiple cancers. At GRAIL, scientists, engineers, and physicians unite to encourage collaboration to adopt new technologies that can transform cancer screening. Discover its Galleri® multi-cancer early detection test at GRAIL.com or Galleri.com.